NASD · Industrials · Integrated Freight & Logistics · USA
Quanome Technologies Inc is a micro cap company (market value under $300 million) in the Integrated Freight & Logistics industry.
Quanome Technologies distributes pharmaceutical products including infusions, medical nutrition and specialty drugs to hospitals and healthcare providers through Hupan Pharmaceutical. The company is also developing quantum-related technologies and offering artificial intelligence computing infrastructure services, both currently in preliminary stages without revenue generation.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Quanome Technologies Inc stock.
Overvalued: intrinsic value $0.19 per share, market price $0.30, margin of safety -61.2% (as of 2026-11-17).
Its liquidation floor, current assets minus every liability, values the shares at $0.19; the price of $0.30 is 61% above that value.
All 32 Integrated Freight & Logistics stocks
4 more in this industry show a wider margin of safety.
QNME is overvalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $0.19; the price of $0.30 is 61% above that value.
$0.19 per share (as of the 2026-11-17 close), against a market price of $0.30. That is a margin of safety of -61.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.